Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New CDK inhibitors patented by Nuvation Bio

Jan. 27, 2021

Qilu Regor Therapeutics patent details MAP4K1 inhibitors

Jan. 27, 2021

Boragen presents new tyrosine kinase inhibitors

Jan. 27, 2021

Medshine Discovery patents new PORCN inhibitors

Jan. 27, 2021

Incyte divulges FGFR-3 inhibitors

Jan. 27, 2021

AR agonist-based strategy proposed for ER+ breast cancer

Jan. 26, 2021

Roche synthesizes MGL inhibitors

Jan. 26, 2021

Exelixis initiates first-in-human study of XL-102 in advanced or metastatic solid tumors

Jan. 26, 2021

Japanese approval of Calquence for relapsed or refractory CLL

Jan. 25, 2021

FDA approves Cabometyx plus Opdivo for advanced RCC

Jan. 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...